This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Michael D. Witt, PharmD, JD
Technology Resource Group Sacramento, Calif

Lawrence O. Gostin, JD
American Society of Law Boston, Mass

JAMA. 1994;272(16):1254.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—In the context raised by Dr Nahata, industry support for the publication of a review article should be viewed as part of a company's marketing efforts, namely, to provide an incentive for a professional to publish his or her opinion about the company's product. Presumably, the company's fiscal motives are to encourage others to rely on the author's assessment of the product and, thus, influence sales. Companies may benefit most from supporting well-written articles by skeptical academics who happen to agree with company positions. Nahata differs from our view insofar as he suggests that the content of such articles are controlled by the sponsoring company. Product endorsement articles lacking objectivity seldom survive journal peer review processes. Further, most scholars realize that it reflects poorly on their academic career if objectivity and professionalism are influenced by financial inducements.

Many peer-reviewed publications, including JAMA, require authors to disclose sources of . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?